共 50 条
Decision-making by the NICE Interventional Procedures Advisory Committee
被引:4
|作者:
Carroll, C.
[1
]
Dickson, R.
[2
]
Boland, A.
[2
]
Houten, R.
[2
]
Walton, M.
[3
]
机构:
[1] Univ Sheffield, Sch Hlth & Related Res, Regent St, Sheffield S1 4DA, S Yorkshire, England
[2] Univ Liverpool, Inst Populat Hlth Sci, Liverpool, Merseyside, England
[3] Univ York, Ctr Reviews & Disseminat, York, N Yorkshire, England
关键词:
D O I:
10.1002/bjs.11334
中图分类号:
R61 [外科手术学];
学科分类号:
摘要:
Background This study explored the evidence base for recommendations by the National Institute of Health and Care Excellence (NICE) Interventional Procedures Advisory Committee, the only NICE committee not to consider cost. The four potential recommendations are: Standard Arrangements (can be performed as routine practice in the NHS); Special Arrangements (can be done under certain conditions); Research Only; and Do Not Do. Methods Quantitative content analysis of data extracted from all published Interventional Procedure Guidance (IPG) for 2003-2018 (n = 496) was undertaken. All data were extracted independently by two researchers; disagreements were clarified by consensus. Data were tabulated, descriptive statistics produced, and regression analyses performed. Results The proportion of IPGs by recommendation was: 50 center dot 0 per cent Standard Arrangements; 37 center dot 2 per cent Special Arrangements; 11 center dot 1 per cent Research Only; and 1 center dot 6 per cent Do Not Do. There was a clear trend over time: the proportion of recommendations for Standard Arrangements decreased, whereas the evidence threshold increased. Adjusted mean numbers of patients in the evidence base by recommendation type were: Standard, 4867; Special, 709; Research Only, 386. Regression analyses confirmed that the year of recommendation, numbers of patients and levels of evidence all affected the likely recommendation. Conclusion This study suggests that the likelihood of achieving the most positive recommendation (Standard Arrangements) is decreasing, and that this is most likely due to evidential requirements becoming more demanding. These findings are distinct from those reported for other NICE committees, for which the cost and statistical superiority of new therapies are among the drivers of recommendations.
引用
收藏
页码:1769 / 1773
页数:5
相关论文